2012
DOI: 10.1007/s10719-012-9417-y
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of dolichol-linked glycosylation

Abstract: In the majority of congenital disorders of glycosylation, the assembly of the glycan precursor GlcNAc2Man9Glc3 on the polyprenol carrier dolichyl-pyrophosphate is compromised. Because N-linked glycosylation is essential to life, most types of congenital disorders of glycosylation represent partial losses of enzymatic activity. Consequently, increased availability of substrates along the glycosylation pathway can be beneficial to increase product formation by the compromised enzymes. Recently, we showed that in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(22 citation statements)
references
References 53 publications
(51 reference statements)
0
21
0
1
Order By: Relevance
“…It is possible that the unique N ‐acetylglucosamine (GlcNAc) end of LNT2 is responsible for this protective effect. The process of N ‐glycosylation starts with the synthesis of precursor oligosaccharides and formation of a dolichol‐linked GlcNAc sugar . The GlcNAc end of LNT2 might serve as a substrate for the N ‐glycosylation and therefore prevent Tm‐induced decline of mucus synthesis genes.…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that the unique N ‐acetylglucosamine (GlcNAc) end of LNT2 is responsible for this protective effect. The process of N ‐glycosylation starts with the synthesis of precursor oligosaccharides and formation of a dolichol‐linked GlcNAc sugar . The GlcNAc end of LNT2 might serve as a substrate for the N ‐glycosylation and therefore prevent Tm‐induced decline of mucus synthesis genes.…”
Section: Discussionmentioning
confidence: 99%
“…Dolichol is synthesized by cis-prenyltransferase, starting from farnesylpyrophosphate and the sequential addition of C 5 isoprenoid units [7,8]. Alterations in dolichol biosynthesis severely affect the N-glycosylation process [9] and can result in a recently described class of congenital disorders of glycosylation (CDG) [10].…”
Section: Dolichol the Lipid Carrier In Er Glycosylationmentioning
confidence: 99%
“…S1C) (Cantagrel & Lefeber, 2011;Helenius & Aebi, 2004;Larkin & Imperiali, 2011;Schwarz & Aebi, 2011;Welti, 2013). This review will focus on the enzymes in eukaryotes and prokaryotes that generate the monophosphorylated lipid carrier either through phosphorylation of the alcohol or dephosphorylation of the pyrophosphate polyisoprenoid moiety, with the latter being coupled to de novo synthesis of the lipid carrier or through a recycling pathway.…”
Section: Introductionmentioning
confidence: 99%